Your browser doesn't support javascript.
loading
The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
Cornec-Le Gall, Emilie; Audrézet, Marie-Pierre; Rousseau, Annick; Hourmant, Maryvonne; Renaudineau, Eric; Charasse, Christophe; Morin, Marie-Pascale; Moal, Marie-Christine; Dantal, Jacques; Wehbe, Bassem; Perrichot, Régine; Frouget, Thierry; Vigneau, Cécile; Potier, Jérôme; Jousset, Philippe; Guillodo, Marie-Paule; Siohan, Pascale; Terki, Nazim; Sawadogo, Théophile; Legrand, Didier; Menoyo-Calonge, Victorio; Benarbia, Seddik; Besnier, Dominique; Longuet, Hélène; Férec, Claude; Le Meur, Yannick.
Afiliação
  • Cornec-Le Gall E; Department of Nephrology, University Hospital, Brest, France; European University of Brittany, Brest, France; National Institute of Health and Medical Sciences, INSERM U1078, Brest, France;
  • Audrézet MP; National Institute of Health and Medical Sciences, INSERM U1078, Brest, France; Department of Molecular Genetics, University Hospital, Brest, France;
  • Rousseau A; Department of Pharmacology, INSERM U850, University Hospital, Limoges, France;
  • Hourmant M; Department of Nephrology, University Hospital, Nantes, France;
  • Renaudineau E; Department of Nephrology, Broussais Hospital, Saint Malo, France;
  • Charasse C; Department of Nephrology, Yves Le Foll Hospital, Saint Brieuc, France;
  • Morin MP; Department of Nephrology, University Hospital, Rennes, France;
  • Moal MC; Department of Nephrology, University Hospital, Brest, France;
  • Dantal J; Department of Nephrology, University Hospital, Nantes, France;
  • Wehbe B; Department of Nephrology, Laennec Hospital, Quimper, France;
  • Perrichot R; Department of Nephrology, Vannes Hospital, Vannes, France;
  • Frouget T; Department of Nephrology, University Hospital, Rennes, France;
  • Vigneau C; Department of Nephrology, University Hospital, Rennes, France;
  • Potier J; Department of Nephrology, Yves Le Foll Hospital, Saint Brieuc, France;
  • Jousset P; Department of Nephrology, Pontivy Hospital, Pontivy, France;
  • Guillodo MP; AUB Santé, Brest, France;
  • Siohan P; Department of Nephrology, Laennec Hospital, Quimper, France;
  • Terki N; SBRA, Hemodialysis Unit, Brest, France;
  • Sawadogo T; Department of Nephrology, Lorient Hospital, Lorient, France;
  • Legrand D; AUB Santé, Lorient, France;
  • Menoyo-Calonge V; ECHO Dialysis Unit, Vannes, France;
  • Benarbia S; AUB Santé, Quimper, France;
  • Besnier D; Department of Nephrology, Saint Nazaire Hospital, Saint Nazaire, France;
  • Longuet H; Department of Nephrology, University Hospital, Tours, France; and.
  • Férec C; European University of Brittany, Brest, France; National Institute of Health and Medical Sciences, INSERM U1078, Brest, France; Department of Molecular Genetics, University Hospital, Brest, France; EFS Bretagne, Brest, France.
  • Le Meur Y; Department of Nephrology, University Hospital, Brest, France; European University of Brittany, Brest, France; yannick.lemeur@chu-brest.fr.
J Am Soc Nephrol ; 27(3): 942-51, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26150605
ABSTRACT
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD before 40 years of age and others never requiring RRT. In this study, we developed a prognostic model to predict renal outcomes in patients with ADPKD on the basis of genetic and clinical data. We conducted a cross-sectional study of 1341 patients from the Genkyst cohort and evaluated the influence of clinical and genetic factors on renal survival. Multivariate survival analysis identified four variables that were significantly associated with age at ESRD onset, and a scoring system from 0 to 9 was developed as follows being male 1 point; hypertension before 35 years of age 2 points; first urologic event before 35 years of age 2 points; PKD2 mutation 0 points; nontruncating PKD1 mutation 2 points; and truncating PKD1 mutation 4 points. Three risk categories were subsequently defined as low risk (0-3 points), intermediate risk (4-6 points), and high risk (7-9 points) of progression to ESRD, with corresponding median ages for ESRD onset of 70.6, 56.9, and 49 years, respectively. Whereas a score ≤3 eliminates evolution to ESRD before 60 years of age with a negative predictive value of 81.4%, a score >6 forecasts ESRD onset before 60 years of age with a positive predictive value of 90.9%. This new prognostic score accurately predicts renal outcomes in patients with ADPKD and may enable the personalization of therapeutic management of ADPKD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteinúria / Algoritmos / Rim Policístico Autossômico Dominante / Hipertensão / Falência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteinúria / Algoritmos / Rim Policístico Autossômico Dominante / Hipertensão / Falência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article